Lyme Disease Diagnosis
C6 Lyme antibody test does not require Western blot for confirmation
Published in Medical Letter on the CDC and FDA, December 19th, 2004
According to a study from the United States, "Three commercial Lyme disease Western immunoblotting (WB) kits and the C6 Borrelia burgdorferi (Lyme) enzyme-linked immunosorbent assay (ELISA) kit were compared using two commercially available performance panels from the Centers for Disease Control and Prevention (CDC) and Boston Biomedica (BBI). Combined, the panels consisted of 52 characterized specimens. Immunoglobulin G (IgG) sensitivity was similar for the three WB products."
"The BBI and Marblot WBs were more specific for IgG antibodies,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Ebola Virus
Ebola amino acid motif required for interferon antagonism - Influenza Virus
H2N2 and early H3N2 influenza viruses exhibit genetic divergence - Occupational Health
Respiratory protection against bioaerosols reviewed - SARS Diagnosis
Laboratory diagnosis of SARS in Guangdong Province, China, described - AIDS/HIV Vaccine
Depo-Provera before SIV challenge eliminates lentivirus-induced protection - AIDS/HIV Vaccine
Non-neutralizing anti-HIV-1 antibody becomes neutralizing antibody - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
